Roehrhoff to succeed Herberg as Gerresheimer ceo

Company: Gerresheimer

Gerresheimer\'s chief executive Axel Herberg will step down and leave the company\'s management board when his contract expires in June. His successor will be Uwe Roehrhoff.

Gerresheimer's chief executive Axel Herberg will step down and leave the company's management board when his contract expires in June. His successor will be Uwe Roehrhoff. Herberg has spent nearly 20 years in top management with Gerresheimer. In the past 10 years as ceo he has shaped the Duesseldorf company's development into an international supplier of glass and plastic vials and drug delivery systems to the pharma and healthcare industries. He was also instrumental in the successful flotation of Gerresheimer AG. Herberg has worked with his successor for many years. Roehrhoff has also been with Gerresheimer for 20 years. He was appointed to the management board in 2003 and took responsibility for the development of Gerresheimer's business in the US and China. Gerresheimer has also appointed Hans-Juergen Wiecha as chief financial officer for a further five years.

You may also like

Manufacturing

Gerresheimer and Portal Instruments team up to commercialise PRIME Nexus reusable autoinjector

Gerresheimer and Portal Instruments are joining forces to develop and manufacture the PRIME Nexus syringe-based, reusable, connected autoinjector platform, offering pharmaceutical companies an end-to-end solution for delivering chronic disease therapies
Manufacturing

Gerresheimer reports H1 2025 growth driven by Bormioli Pharma acquisition

Cosmetics and oral liquids markets dampen organic revenue but outlook remains strong
Manufacturing

Gerresheimer database accelerates drug registration and approval

Audit-proof documentation and packaging insight reduce time-to-market for pharma customers
Packaging

Gerresheimer & Bormioli Pharma make their first joint trade show appearance at Pharmapack 2025

The companies will showcase their containment and primary packaging solutions, as well as their digital and drug delivery systems for the pharmaceutical market
Manufacturing

Gerresheimer begins €100m expansion of its pharmaceutical syringe production capabilities

The extension of its Skopje, North Macedonia site will allow Gerresheimer to better serve the pharmaceutical and biotech industries
Drug Delivery

Gerresheimer's Gx Inbeneo wins Red Dot award

The company's autoinjector allows patients to effectively self-administer biologics in the comfort of their own home
Manufacturing

SCHOTT, Gerresheimer and Stevanato Group form the 'Alliance for RTU'

The scheme will promote the adoption of ready-to-use (RTU) vials and cartridges for CDMOs in the injectable scene
Subscribe now